John Brognard
Company: National Cancer Institute (NCI) in NIH
Job title: Earl Stadtman Investigator
Seminars:
Innovating PROTACs to Surpass Limitations of Traditional Kinase Inhibitors for Elevated Tumor Targeting 1:45 pm
Demonstrating unique mechanisms employed by PROTACs to promote targeted degradation of kinases Testing various combinations of chemical motifs and linker chemistries to produce effective PROTACs Streamlining the design of potent and selective PROTACs through anchor-linkerwarhead combinations for maximized degradation efficiencyRead more
day: Conference Day Two